review article | Q7318358 |
meta-analysis | Q815382 |
scholarly article | Q13442814 |
P356 | DOI | 10.1093/CID/CIW649 |
P698 | PubMed publication ID | 27678085 |
P50 | author | Eleftherios Mylonakis | Q56769876 |
P2093 | author name string | Aisling R Caffrey | |
Kerry L LaPlante | |||
Kevin W McConeghy | |||
Tristan T Timbrook | |||
Jacob B Morton | |||
P2860 | cites work | Effectiveness of Practices To Increase Timeliness of Providing Targeted Therapy for Inpatients with Bloodstream Infections: a Laboratory Medicine Best Practices Systematic Review and Meta-analysis | Q26776404 |
Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe | Q27027680 | ||
Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
Meta-analysis in clinical trials | Q27860779 | ||
Impact of rapid organism identification via matrix-assisted laser desorption/ionization time-of-flight combined with antimicrobial stewardship team intervention in adult patients with bacteremia and candidemia | Q31125537 | ||
Hospital-acquired, laboratory-confirmed bloodstream infections: linking national surveillance data to clinical and financial hospital data to estimate increased length of stay and healthcare costs | Q33551866 | ||
Real-time PCR testing for mecA reduces vancomycin usage and length of hospitalization for patients infected with methicillin-sensitive staphylococci | Q33704733 | ||
Impact of antimicrobial stewardship intervention on coagulase-negative Staphylococcus blood cultures in conjunction with rapid diagnostic testing | Q34058641 | ||
National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases | Q34309458 | ||
Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs | Q34502129 | ||
Assessment of impact of peptide nucleic acid fluorescence in situ hybridization for rapid identification of coagulase-negative staphylococci in the absence of antimicrobial stewardship intervention | Q35066918 | ||
Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia | Q35170970 | ||
Clinical impact of a real-time PCR assay for rapid identification of staphylococcal bacteremia | Q35668314 | ||
Integrating Rapid Diagnostics and Antimicrobial Stewardship in Two Community Hospitals Improved Process Measures and Antibiotic Adjustment Time | Q35887408 | ||
Randomized Trial of Rapid Multiplex Polymerase Chain Reaction-Based Blood Culture Identification and Susceptibility Testing. | Q36030480 | ||
A Stewardship Approach To Optimize Antimicrobial Therapy through Use of a Rapid Microarray Assay on Blood Cultures Positive for Gram-Negative Bacteria | Q36173894 | ||
Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections | Q36837889 | ||
Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy | Q36932977 | ||
Clinical Impact of Laboratory Implementation of Verigene BC-GN Microarray-Based Assay for Detection of Gram-Negative Bacteria in Positive Blood Cultures | Q37040468 | ||
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America | Q37220711 | ||
Better tests, better care: improved diagnostics for infectious diseases | Q37287115 | ||
Stewardship approach for optimizing antimicrobial therapy through use of a rapid microarray assay on blood cultures positive for Enterococcus species | Q37336208 | ||
Review of rapid diagnostic tests used by antimicrobial stewardship programs | Q38254825 | ||
Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range | Q38294119 | ||
Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs | Q38475730 | ||
Impact of a Rapid Blood Culture Assay for Gram-Positive Identification and Detection of Resistance Markers in a Pediatric Hospital | Q39959054 | ||
Prospective intervention study with a microarray-based, multiplexed, automated molecular diagnosis instrument (Verigene system) for the rapid diagnosis of bloodstream infections, and its impact on the clinical outcomes. | Q40470766 | ||
Impact of a rapid multiplex polymerase chain reaction blood culture identification technology on outcomes in patients with vancomycin-resistant Enterococcal bacteremia | Q40667972 | ||
Impact of the multiplex polymerase chain reaction in culture-positive samples on appropriate antibiotic use in patients with staphylococcal bacteremia | Q40829295 | ||
Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel | Q40881927 | ||
Outcomes of rapid identification for gram-positive bacteremia in combination with antibiotic stewardship at a community-based hospital system. | Q41384383 | ||
Impact of a rapid microarray-based assay for identification of positive blood cultures for treatment optimization for patients with streptococcal and enterococcal bacteremia | Q41488631 | ||
Impact of same-day antibiotic susceptibility testing on time to appropriate antibiotic treatment of patients with bacteraemia: a randomised controlled trial. | Q41589486 | ||
Clinical impact of a PCR assay for rapid identification of Klebsiella pneumoniae in blood cultures | Q41913418 | ||
Risk of bias versus quality assessment of randomised controlled trials: cross sectional study | Q42081186 | ||
An antimicrobial stewardship program's impact with rapid polymerase chain reaction methicillin-resistant Staphylococcus aureus/S. aureus blood culture test in patients with S. aureus bacteremia | Q42873721 | ||
Impact of a rapid peptide nucleic acid fluorescence in situ hybridization assay on treatment of Candida infections | Q45220026 | ||
Direct mecA polymerase chain reaction testing of blood culture bottles growing Gram-positive cocci and the clinical potential in optimizing antibiotic therapy for staphylococcal bacteremia | Q46451322 | ||
Clinical impact of a real-time PCR assay for rapid identification of Staphylococcus aureus and determination of methicillin resistance from positive blood cultures. | Q54432834 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | meta-analysis | Q815382 |
systematic review | Q1504425 | ||
P304 | page(s) | 15-23 | |
P577 | publication date | 2016-09-26 | |
P1433 | published in | Clinical Infectious Diseases | Q5133764 |
P1476 | title | The Effect of Molecular Rapid Diagnostic Testing on Clinical Outcomes in Bloodstream Infections: A Systematic Review and Meta-analysis | |
P478 | volume | 64 |
Q91902727 | A Systematic Review and Meta-analysis of Antibiotic Treatment Duration for Bacteremia Due to Enterobacteriaceae |
Q89080678 | A rare fungus on the rise: Candida auris |
Q90405143 | Accelerating Initiation of Adequate Antimicrobial Therapy Using Real-Time Decision Support and Microarray Testing |
Q52372579 | An Antibiotic Stewardship Program Blueprint for Optimizing Verigene BC-GN within an Institution: a Tale of Two Cities. |
Q55262380 | An Automated Sample Preparation Instrument to Accelerate Positive Blood Cultures Microbial Identification by MALDI-TOF Mass Spectrometry (Vitek®MS). |
Q91699767 | Antibiotic stewardship in the intensive care unit: Challenges and opportunities |
Q64128215 | Antimicrobial susceptibility testing of pathogens isolated from blood culture: a performance comparison of Accelerate Pheno™ and VITEK® 2 systems with the broth microdilution method |
Q89669079 | Bloodstream infections in critically ill patients: an expert statement |
Q90087449 | Challenges and research priorities to progress the impact of antimicrobial stewardship |
Q93037645 | Clinical Performance of the Novel GenMark Dx ePlex Blood Culture ID Gram-Positive Panel |
Q92883659 | Clinical Utility of Advanced Microbiology Testing Tools |
Q91969987 | Collaborative Antimicrobial Stewardship: Working with Microbiology |
Q64949952 | Comparing Patient Risk Factor-, Sequence Type-, and Resistance Locus Identification-Based Approaches for Predicting Antibiotic Resistance in Escherichia coli Bloodstream Infections. |
Q57461242 | Comparison of Pharmacist-Directed Management of Multiplex PCR Blood Culture Results with Conventional Microbiology Methods on Effective and Optimal Therapy within a Community Hospital |
Q64953308 | Comparison of the Fully Automated FilmArray BCID Assay to a 4-Hour Culture Test Coupled to Mass Spectrometry for Day 0 Identification of Microorganisms in Positive Blood Cultures. |
Q91675647 | Development of a Multiplex PCR Platform for the Rapid Detection of Bacteria, Antibiotic Resistance, and Candida in Human Blood Samples |
Q91674620 | Diagnosing and Managing Sepsis by Probing the Host Response to Infection: Advances, Opportunities, and Challenges |
Q53701537 | Diagnostic Stewardship: Opportunity for a Laboratory-Infectious Diseases Partnership. |
Q49609584 | Disease-based antimicrobial stewardship: a review of active and passive approaches to patient management. |
Q95264399 | ERS International Congress, Madrid, 2019: highlights from the Respiratory Infections Assembly |
Q36287903 | Effect of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) Alone versus MALDI-TOF MS Combined with Real-Time Antimicrobial Stewardship Interventions on Time to Optimal Antimicrobial Therapy in Patients with |
Q53690859 | Evaluation of a real-time PCR assay for detection and quantification of bacterial DNA directly in blood of preterm neonates with suspected late-onset sepsis. |
Q49545992 | Evaluation of the Accelerate Pheno™ System: Results from Two Academic Medical Centers. |
Q58440392 | Evaluation of the Accelerate Pheno™ system for rapid identification and antimicrobial susceptibility testing of Gram-negative bacteria in bloodstream infections |
Q58577357 | Impact of a Multiplex PCR Assay for Bloodstream Infections With and Without Antimicrobial Stewardship Intervention at a Cancer Hospital |
Q90016262 | Impact of an Antimicrobial Stewardship Bundle for Uncomplicated Gram-Negative Bacteremia |
Q40202447 | Impact of antimicrobial stewardship and rapid microarray testing on patients with Gram-negative bacteremia |
Q91994650 | Impact of infectious diseases consultation on the outcome of patients with bacteraemia |
Q96638650 | Impact of rapid diagnostics with antimicrobial stewardship support for children with positive blood cultures: A quasi-experimental study with time trend analysis |
Q40109286 | Impact of rapid identification of positive blood cultures using the Verigene system on antibiotic prescriptions: A prospective study of community-onset bacteremia in a tertiary hospital in Japan. |
Q89408653 | Implementation and optimization of molecular rapid diagnostic tests for bloodstream infections |
Q100572679 | Implementation of infectious diseases rapid molecular diagnostic tests and antimicrobial stewardship program involvement in acute-care hospitals |
Q99356953 | Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals |
Q40083539 | Incidence, prevalence, and management of MRSA bacteremia across patient populations-a review of recent developments in MRSA management and treatment |
Q60949850 | Laboratory Automation in Clinical Microbiology |
Q58781572 | Management and outcome of bloodstream infections: a prospective survey in 121 French hospitals (SPA-BACT survey) |
Q38737360 | Molecular antibiogram in diagnostic clinical microbiology: advantages and challenges |
Q48300852 | Multicenter Evaluation of the Accelerate PhenoTest™ BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis. |
Q40218550 | Pharmacists' Familiarity with and Institutional Utilization of Rapid Diagnostic Technologies for Antimicrobial Stewardship. |
Q60937003 | Predictors of Time to Effective and Optimal Antimicrobial Therapy in Patients With Positive Blood Cultures Identified via Molecular Rapid Diagnostic Testing |
Q47398868 | Recent advances in the microbiological diagnosis of bloodstream infections. |
Q50123871 | Research Agenda for Antimicrobial Stewardship in the Veterans Health Administration. |
Q47647007 | Risk Factors and Outcomes for Ineffective Empiric Treatment of Sepsis Caused by Gram-Negative Pathogens: Stratification by Onset of Infection |
Q40067736 | Significant Publications on Infectious Diseases Pharmacotherapy in 2016. |
Q89414736 | Surviving sepsis campaign: research priorities for sepsis and septic shock |
Q64261054 | Susceptibility Provision Enhances Effective De-escalation (SPEED): utilizing rapid phenotypic susceptibility testing in Gram-negative bloodstream infections and its potential clinical impact |
Q41992934 | Sustained impact of a rapid microarray-based assay with antimicrobial stewardship interventions on optimizing therapy in patients with Gram-positive bacteraemia |
Q47710544 | Syndromic Panel-Based Testing in Clinical Microbiology. |
Q88923903 | The Cost-Effectiveness of Rapid Diagnostic Testing for the Diagnosis of Bloodstream Infections with or without Antimicrobial Stewardship |
Q90594919 | The Hypothetical Impact of Accelerate Pheno on Time to Effective Therapy and Time to Definitive Therapy for Bloodstream Infections Due to Drug-Resistant Gram-Negative Bacilli |
Q50048893 | The Role of an Antimicrobial Stewardship Team in the Use of Rapid Diagnostic Testing in Acute Care: An Official Position Statement of the Society of Infectious Diseases Pharmacists. |
Q90306449 | The impact of a rapid molecular identification test on positive blood cultures from critically ill with bacteremia: A pre-post intervention study |
Q30238578 | The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship. |
Q50048345 | Understanding inpatient antimicrobial stewardship metrics. |
Q90167656 | Using Genetic Distance from Archived Samples for the Prediction of Antibiotic Resistance in Escherichia coli |
Q90653096 | Validation of an Antimicrobial Stewardship-Driven Verigene Blood-Culture Gram-Negative Treatment Algorithm to Improve Appropriateness of Antibiotics |
Q91607474 | Variability in antifungal stewardship strategies among Society for Healthcare Epidemiology of America (SHEA) Research Network facilities |
Q91765584 | Will biomarkers be the answer for antibiotic stewardship? |
Search more.